Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Shapiro (Pittsburgh, Pa, United States of America). Matrix interaction with the epithelium – clinical outcomes. Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis

Member's Comments

No comment yet.

Related content which might interest you: Oral presentation: Hypoxia-induced EMT in primary human small airway epithelium is controlled by extracellular matrix interactions Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Gene expression signatures in airway and nasal epithelium of COPD: linking endotypes to clinical outcomes Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes Year: 2017 Matrix metalloproteinase levels of bronchial mucosa and the correlation with clinical parameters in clinically stable bronchiectasis Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Hypoxia-induced EMT in primary human small airway epithelium is controlled by extracellular matrix interactions Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Presentation by an expert: Epithelial barrier biology: interactions between the epithelium and lymphocytes in disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Matrix metalloproteinase (MMP) 12 is associated with clinical parameters of disease severity and exacerbations in asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 Analysis of pathological changes in the epithelium in COVID-19 patient airways Source: ERJ Open Res, 7 (2) 00690-2020; 10.1183/23120541.00690-2020 Year: 2021 Clustering of adherence variability metrics and clinical outcomes in asthma Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Interpreting lung function in clinical practice Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease Year: 2006 Osteopontin expression and relation to disease severity in human asthma Source: Eur Respir J 2011; 37: 331 Year: 2011 Matrix metalloproteinase (MMP) 12 is not associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010 LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 The impact of embedding trial recruitment into a clinical care pathway Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond Year: 2021 Matrix metalloproteinase (MMP) 9 is associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010 The effect of current therapeutic modalities on epithelial barrier defects and remodelling Source: International Congress 2014 – Epithelial barrier dysfunction: the link between paediatric and adult respiratory diseases Year: 2014 BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Early bronchial basement membrane thickening does not predict lung function impairment in preschool age Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016